Evidence map›Paper›PMID 29570419›Full record

ArticleJournal of clinical oncology : official journal of the American Society of Clinical Oncology2018

Age-Associated Mortality Risk in Papillary Thyroid Cancer: Does BRAF Make a Real Difference?

Miguel Melo, Adriana Gaspar da Rocha, Gustavo Cancela E Penna, Manuel Sobrinho-Simões, Paula Soares

Abstract readLetterComment
PubMed Publisher
In one paragraph

Article in Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Review
  2. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

5 authors.

Miguel MeloMiguel Melo, Instituto de Investigação e Inovação em Saúde, University of Porto, Porto; Centro Hospitalar e Universitário de Coimbra, University of Coimbra, Coimbra, Portugal; Adriana Gaspar da Rocha, Instituto de Investigação e Inovação em Saúde, University of Porto, Porto; ACeS Baixo Mondego, Coimbra, Portugal; Gustavo Cancela e Penna, Federal University of Minas Gerais; Hospital Mater Dei, Belo Horizonte, Minas Gerais; Federal University of Rio de Janeiro, Rio de Janeiro, Brazil; Manuel Sobrinho-Simões, Instituto de Investigação e Inovação em Saúde, University of Porto, Hospital S. João, Porto, Portugal; and Paula Soares, Instituto de Investigação e Inovação em Saúde, University of Porto, Porto, Portugal.
Adriana Gaspar da RochaMiguel Melo, Instituto de Investigação e Inovação em Saúde, University of Porto, Porto; Centro Hospitalar e Universitário de Coimbra, University of Coimbra, Coimbra, Portugal; Adriana Gaspar da Rocha, Instituto de Investigação e Inovação em Saúde, University of Porto, Porto; ACeS Baixo Mondego, Coimbra, Portugal; Gustavo Cancela e Penna, Federal University of Minas Gerais; Hospital Mater Dei, Belo Horizonte, Minas Gerais; Federal University of Rio de Janeiro, Rio de Janeiro, Brazil; Manuel Sobrinho-Simões, Instituto de Investigação e Inovação em Saúde, University of Porto, Hospital S. João, Porto, Portugal; and Paula Soares, Instituto de Investigação e Inovação em Saúde, University of Porto, Porto, Portugal.
Gustavo Cancela E PennaMiguel Melo, Instituto de Investigação e Inovação em Saúde, University of Porto, Porto; Centro Hospitalar e Universitário de Coimbra, University of Coimbra, Coimbra, Portugal; Adriana Gaspar da Rocha, Instituto de Investigação e Inovação em Saúde, University of Porto, Porto; ACeS Baixo Mondego, Coimbra, Portugal; Gustavo Cancela e Penna, Federal University of Minas Gerais; Hospital Mater Dei, Belo Horizonte, Minas Gerais; Federal University of Rio de Janeiro, Rio de Janeiro, Brazil; Manuel Sobrinho-Simões, Instituto de Investigação e Inovação em Saúde, University of Porto, Hospital S. João, Porto, Portugal; and Paula Soares, Instituto de Investigação e Inovação em Saúde, University of Porto, Porto, Portugal.
Manuel Sobrinho-SimõesMiguel Melo, Instituto de Investigação e Inovação em Saúde, University of Porto, Porto; Centro Hospitalar e Universitário de Coimbra, University of Coimbra, Coimbra, Portugal; Adriana Gaspar da Rocha, Instituto de Investigação e Inovação em Saúde, University of Porto, Porto; ACeS Baixo Mondego, Coimbra, Portugal; Gustavo Cancela e Penna, Federal University of Minas Gerais; Hospital Mater Dei, Belo Horizonte, Minas Gerais; Federal University of Rio de Janeiro, Rio de Janeiro, Brazil; Manuel Sobrinho-Simões, Instituto de Investigação e Inovação em Saúde, University of Porto, Hospital S. João, Porto, Portugal; and Paula Soares, Instituto de Investigação e Inovação em Saúde, University of Porto, Porto, Portugal.
Paula SoaresMiguel Melo, Instituto de Investigação e Inovação em Saúde, University of Porto, Porto; Centro Hospitalar e Universitário de Coimbra, University of Coimbra, Coimbra, Portugal; Adriana Gaspar da Rocha, Instituto de Investigação e Inovação em Saúde, University of Porto, Porto; ACeS Baixo Mondego, Coimbra, Portugal; Gustavo Cancela e Penna, Federal University of Minas Gerais; Hospital Mater Dei, Belo Horizonte, Minas Gerais; Federal University of Rio de Janeiro, Rio de Janeiro, Brazil; Manuel Sobrinho-Simões, Instituto de Investigação e Inovação em Saúde, University of Porto, Hospital S. João, Porto, Portugal; and Paula Soares, Instituto de Investigação e Inovação em Saúde, University of Porto, Porto, Portugal.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Carcinoma, PapillaryThyroid Cancer, PapillaryThyroid NeoplasmsHumansProto-Oncogene Proteins B-rafBRAF protein, humanProto-Oncogene Proteins B-raf

Identifiers

PMID29570419

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.